In Vitro Fertilization (IVF) Market in Russia, Brief Analysis By Top Key players Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of The Reproductive Medicines) and Many Others

The IVF market size in Russia was valued at $398 million in 2015, and is projected to reach $641 million by 2022, growing at a CAGR of 7.0% from 2016 to 2022. Non-assisted IVF cycles are projected to witness the highest growth rate from 2016 to 2022.

Fertility clinics and hospitals collectively contributed about three-fourths of the market revenue in 2014. This is attributed to their crucial role in providing technologically advanced IVF treatment to couples seeking assistance for infertility treatment.

Download Report Sample https://www.alliedmarketresearch.com/request-sample/2389

In vitro fertilization (IVF) is an assisted reproductive technology (ART) that involves extraction of eggs, sample retrieval of sperm cells, followed by manual combination of an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the womans uterus for further gestation.

The Russia IVF market is driven by increase in incidence of infertility cases, emergent trend of delayed pregnancies among women, technological advancements in IVF procedures, and rise in gamete donation. However, insufficient reimbursement policies related to IVF treatment are anticipated to impede this growth. Moreover, growth in interest of single parents and same-sex couples to experience parenthood through ART, especially IVF, is expected to present various opportunities for market development.

The fertility clinics segment accounted for the highest share of the Russia IVF end user market in 2015, owing to the availability of wide range of fertility treatments under a single roof and applicable government reimbursements. The donor egg IVF cycle type segment is anticipated to witness the highest growth rate from 2016 to 2022. However, the fresh cycle (non-donor) is projected to dominate the cycle type market.

At present, gonadotropins & gonadotropin-releasing hormones dominate the drug segment of the market, and is expected to grow at a CAGR of 6.5% during the forecast period. This is attributable to the effectiveness and safety of this drug to stimulate ovulation during an IVF procedure.

Key Findings of the Russia In Vitro Fertilization (IVF) Market:

• The fertility clinics end-user segment is anticipated to grow at the highest CAGR from 2016 to 2022 in terms of value as well as volume.
• The fresh IVF cycle (non-donor) cycle type segment generated the highest revenue in 2015, and is expected to continue its dominance in the near future.
• ICSI assisted IVF cycles dominated the Russia in vitro fertilizationmarket, and are projected to grow at a CAGR of 6.4%.
• Donor egg IVF cycle type is expected to witness the highest growth rate in terms of value as well as volume during the forecast period.

Get More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2389

The major companies profiled in the report include Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of the Reproductive Medicines).

Table Of Content

Chapter: 1 RUSSIA IVF MARKET
1.1. EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
1.2. RUSSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)
1.2.1. Market size and forecast
1.2.2. Russia IVF market, by end user
1.2.2.1. Market size and forecast
1.2.2.2. Fertility clinics
1.2.2.3. Hospitals
1.2.2.4. Surgical centers
1.2.2.5. Clinical research institutes
1.2.3. Russia IVF market, by cycle type
1.2.3.1. Market size and forecast
1.2.3.2. Fresh IVF cycles (non-donor)
1.2.3.3. Thawed IVF cycles (non-donor)
1.2.3.4. Donor egg IVF cycles
1.2.4. Russia IVF market, by type
1.2.4.1. Market size and forecast
1.2.4.2. Non-ICSI IVF cycles
1.2.4.3. ICSI-assisted IVF cycles
1.2.5. Russia IVF market by pharmacological modality
1.2.5.1. Overview
1.2.5.2. Key trends
1.2.5.3. Market size and forecast
1.2.5.4. Duration of therapy
1.2.5.5. Segmentation of drugs for IVF
1.2.5.5.1. Clomiphene citrate
1.2.5.5.2. Aromatase inhibitors
1.2.5.5.3. Gonadotropins & gonadotropin-releasing hormone (GnRH)
1.2.5.5.4. Follicle-stimulating hormone (FSH)
1.2.5.5.5. Progesterone
1.2.5.5.6. Others
1.2.5.6. Mode of administration
1.2.5.6.1. Oral
1.2.5.6.2. Injectable
1.2.5.6.3. Vaginal
1.2.6. Market dynamics
1.2.6.1. Drivers
1.2.6.1.1. Rise in popularity of fertility tourism
1.2.6.1.2. Advanced IVF facilities and treatment options
1.2.6.2. Restraint
1.2.6.2.1. Inadequate reimbursement policies
1.2.7. Regulatory issues, legislations, and authorities
1.2.8. Insurance reimbursement scenario

Chapter: 2 COMPANY PROFILES
2.1. AVA-PETER CLINIC
2.1.1. Company overview
2.1.2. Company snapshot
2.1.3. Product portfolio
2.2. MD MEDICAL GROUP INVESTMENTS PLC (MD MEDICAL GROUP)
2.2.1. Company overview
2.2.2. Company snapshot
2.2.3. Operating business segments
2.2.4. Product portfolio
2.2.5. Business performance
2.2.6. Key strategic moves and developments
2.3. IVF RUSSIA (THE INTERNATIONAL CENTRE OF THE REPRODUCTIVE MEDICINES)
2.3.1. Company overview
2.3.2. Company snapshot
2.3.3. Operating business segments

Access Full Summery @ https://www.alliedmarketresearch.com/russia-in-vitro-fertilization-IVF-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.